Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triptorelin adverse reaction (disorder) |
Causative agent (attribute) |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Allergy to triptorelin |
Causative agent (attribute) |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Product containing triptorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Triptorelin 4.2mg powder and solvent for injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin pamoate 11.25mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin pamoate 3.75mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin 3.75mg powder and solvent for injection prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin 15mg powder and dilutent for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin pamoate (substance) |
Is a |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin acetate (substance) |
Is a |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Allergy to triptorelin |
Causative agent (attribute) |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Triptorelin acetate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Triptorelin pamoate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
|
Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin 11.25 milligram/1 vial powder for conventional release suspension for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing triptorelin in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Triptorelin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Triptorelin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial lyophilized powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin (as triptorelin pamoate) 11.25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely triptorelin (as triptorelin pamoate) 22.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Triptorelin (substance) |
Inferred relationship |
Some |
1 |